Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for PD-L1 (gene)
Most Relevant Literature
- Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy.
- CD274 (PD-L1) negatively regulates M1 macrophage polarization in ALI/ARDS.
- Oral PD-L1 Inhibitors Crowd into the Clinic.
- The current status and future of PD-L1 in liver cancer.
- Discovery of Novel PD-L1 Small-Molecular Inhibitors with Potent In Vivo Anti-tumor Immune Activity.
Most Relevant Clinical Trials
- Effect of Chemotherapy on PD-L1 in NSCLC
- Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
- GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC
- A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors
- Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanom…
